Jorge Monge, M.D., is an Assistant Professor of Medicine in the Division of Hematology at University of Colorado.

Dr. Monge received his M.D. from Anahuac University in Mexico City, Mexico. He completed his residency in Internal Medicine at Jackson Memorial Hospital and the University of Miami, and a fellowship in Hematology and Medical Oncology at NewYork-Presbyterian Hospital and Weill Cornell Medical College. Prior to his clinical training, Dr. Monge completed a Postdoctoral Research Fellowship at Mayo Clinic under the guidance of Dr. Rafael Fonseca. During this Research Fellowship, Dr. Monge focused on describing the genomic landscape of high-risk multiple myeloma using targeted DNA sequencing as well as defining the role of calcium isotopic composition on multiple myeloma-induced bone disease and overall disease activity.

Dr. Monge’s current research focuses on the development of new therapies for plasma cell disorders, including multiple myeloma; and reducing outcome disparities in patients with hematologic malignancies by addressing barriers to accessing specialized hematologic care and increasing the representation of ethnic and racial minority groups in clinical trials.